INVESTIGADORES
QUIROGA Ariel Dario
congresos y reuniones científicas
Título:
Loss of Ces1/Es-x in mice results in obesity, increased blood lipid levels and decreased energy expenditure
Autor/es:
QUIROGA, ARIEL DARIO; LI, LENA; PROCTOR, SPENCER; KÖFELER, HC; LEHNER, RICHARD
Lugar:
Madison
Reunión:
Simposio; Steenbock Symposium; 2011
Institución organizadora:
University of Wisconsin, Madison
Resumen:
Mouse
carboxylesterase1/esterase-x (Ces1/Es-x) is a close homolog of
carboxylesterase3/triacylglycerol (TG) hydrolase (Ces3/TGH). Its over-expression
in McArdle-RH7777 (McArdle) cells led to decreased TG levels and to increased β-oxidation when incubated with
oleic acid (Ko et al., 2009). We proposed that mice lacking
the Ces1/Es-x gene would have altered
lipid metabolism. Ces1/Es-x-/-mice on a chow diet presented increased body weight, increased adiposity
and enlarged adipocytes despite the same level of food intake as wild-type mice.
The Ces1/Es-x knockout mice accumulated more lipids in plasma and liver, and
had increased chylomicron and VLDL secretion with delayed lipoprotein
clearance. Hepatocytes from Ces1/Es-x-/-mice showed increased lipid biosynthesis, due to activation of the sterol
regulatory binding protein-1c (SREBP-1c) and its target genes. Ces1/Es-x
deficient mice also accumulated polyunsaturated fatty acid (PUFA) in TG. On the
other hand, McArdle cells stably expressing Ces1/Es-x cDNA, presented with
lower amounts of TG enriched in long chain fatty acids. These experiments
suggested that Ces1/Es-x
might be hydrolyzing long chain fatty acid-enriched TG, presumably,
PUFA-enriched TG. In line with this potential mechanism, incubation of Ces1/Es-x-/- hepatocytes with
PUFA decreased lipid synthesis to the same levels obtained in wild-type
hepatocytes. In conclusion, Ces1/Es-x may regulate lipoprotein
production/secretion and therefore fat accumulation. We found that Ces1/Es-x
protein expression undergoes nutritional regulation and its activity seems to
play a key role in modulating the expression of enzymes that control lipid
biosynthesis. These results make Ces1/Es-x a striking pharmacological candidate
for preventing hepatic steatosis and obesity.
Ko,
K.W., Erickson, B., and Lehner, R. (2009). Es-x/Ces1 prevents triacylglycerol
accumulation in McArdle-RH7777 hepatocytes. Biochimica et biophysica acta 1791, 1133-1143.